4/A//SEC Filing
Hayward James A 4/A
Accession 0001144204-19-035057
CIK 0000744452other
Filed
Jul 17, 8:00 PM ET
Accepted
Jul 18, 4:25 PM ET
Size
8.5 KB
Accession
0001144204-19-035057
Insider Transaction Report
Form 4/AAmended
Hayward James A
DirectorChairman, CEO and President10% Owner
Transactions
- Conversion
Secured Convertible Note
2018-11-29−500,000→ 500,000 totalExercise: $0.54From: 2018-11-29Exp: 2021-11-28→ Common Stock (953,324 underlying) - Conversion
Secured Convertible Note
2018-08-31−1,000,000→ 1,000,000 totalExercise: $0.54From: 2018-08-31Exp: 2021-11-28→ Common Stock (1,935,613 underlying)
Footnotes (2)
- [F1]The Secured convertible note was issued in an exempt transaction pursuant to a securities purchase agreement dated August 31, 2018 at a purchase price of 100% of its principal balance. On July 16, 2019 an amendment to the Secured convertible note was entered into, to, among other things, (i) amend the conversion price to $0.54 from $2.50 and (ii) amend the maturity date of the August 2018 Notes to November 28, 2021.
- [F2]The Secured convertible note was issued in an exempt transaction pursuant to a securities purchase agreement dated November 29, 2018 at a purchase price of 100% of its principal balance. On July 16, 2019 an amendment to the Secured convertible note was entered into, to among other things, amend the conversion price to $0.54 from $2.50.
Documents
Issuer
APPLIED DNA SCIENCES INC
CIK 0000744452
Entity typeother
Related Parties
1- filerCIK 0001357784
Filing Metadata
- Form type
- 4/A
- Filed
- Jul 17, 8:00 PM ET
- Accepted
- Jul 18, 4:25 PM ET
- Size
- 8.5 KB